Periprosthetic Joint Infection After Total Knee Arthroplasty With or Without Antibiotic Bone Cement.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 May 2024
Historique:
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 23 5 2024
Statut: epublish

Résumé

Despite increased use of antibiotic-loaded bone cement (ALBC) in joint arthroplasty over recent decades, current evidence for prophylactic use of ALBC to reduce risk of periprosthetic joint infection (PJI) is insufficient. To compare the rate of revision attributed to PJI following primary total knee arthroplasty (TKA) using ALBC vs plain bone cement. This international cohort study used data from 14 national or regional joint arthroplasty registries in Australia, Denmark, Finland, Germany, Italy, New Zealand, Norway, Romania, Sweden, Switzerland, the Netherlands, the UK, and the US. The study included primary TKAs for osteoarthritis registered from January 1, 2010, to December 31, 2020, and followed-up until December 31, 2021. Data analysis was performed from April to September 2023. Primary TKA with ALBC vs plain bone cement. The primary outcome was risk of 1-year revision for PJI. Using a distributed data network analysis method, data were harmonized, and a cumulative revision rate was calculated (1 - Kaplan-Meier), and Cox regression analyses were performed within the 10 registries using both cement types. A meta-analysis was then performed to combine all aggregated data and evaluate the risk of 1-year revision for PJI and all causes. Among 2 168 924 TKAs included, 93% were performed with ALBC. Most TKAs were performed in female patients (59.5%) and patients aged 65 to 74 years (39.9%), fully cemented (92.2%), and in the 2015 to 2020 period (62.5%). All participating registries reported a cumulative 1-year revision rate for PJI of less than 1% following primary TKA with ALBC (range, 0.21%-0.80%) and with plain bone cement (range, 0.23%-0.70%). The meta-analyses based on adjusted Cox regression for 1 917 190 TKAs showed no statistically significant difference at 1 year in risk of revision for PJI (hazard rate ratio, 1.16; 95% CI, 0.89-1.52) or for all causes (hazard rate ratio, 1.12; 95% CI, 0.89-1.40) among TKAs performed with ALBC vs plain bone cement. In this study, the risk of revision for PJI was similar between ALBC and plain bone cement following primary TKA. Any additional costs of ALBC and its relative value in reducing revision risk should be considered in the context of the overall health care delivery system.

Identifiants

pubmed: 38780939
pii: 2819041
doi: 10.1001/jamanetworkopen.2024.12898
doi:

Substances chimiques

Bone Cements 0
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2412898

Auteurs

Tesfaye H Leta (TH)

The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.
Faculty of Health Science, VID Specialized University, Oslo, Norway.
Department of Population Health Sciences, Weill Medical College of Cornell University, New York, New York.
Medical Device Surveillance and Assessment, Kaiser Permanente, San Diego, California.

Stein Atle Lie (SA)

The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.
Center for Translational Oral Research, Department of Dentistry, University of Bergen, Bergen, Norway.

Anne Marie Fenstad (AM)

The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.

Stein Håkon L Lygre (SHL)

The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.
Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway.

Martin Lindberg-Larsen (M)

The Danish Knee Arthroplasty Register, Odense, Denmark.
Department of Orthopaedic Surgery and Traumatology, Odense University Hospital, Odense, Denmark.

Alma B Pedersen (AB)

The Danish Knee Arthroplasty Register, Odense, Denmark.
Department of Clinical Epidemiology, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Annette W-Dahl (A)

The Swedish Arthroplasty Register, Gothenburg, Sweden.
Department of Clinical Sciences Lund, Orthopedics, Lund University, Lund, Sweden.

Ola Rolfson (O)

The Swedish Arthroplasty Register, Gothenburg, Sweden.
Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Erik Bülow (E)

Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Centre of Registers Västra Götaland, Gothenburg, Sweden.

Liza N van Steenbergen (LN)

The Dutch Arthroplasty Register, 's-Hertogenbosch, the Netherlands.

Rob G H H Nelissen (RGHH)

The Dutch Arthroplasty Register, 's-Hertogenbosch, the Netherlands.
Department Orthopaedics, Leiden University Medical Center, Leiden, the Netherlands.

Dylan Harries (D)

South Australian Health and Medical Research Institute, Adelaide, Australia.

Richard de Steiger (R)

The Australian Orthopaedic Association National Joint Replacement Registry, Adelaide, Australia.

Olav Lutro (O)

Department of Medicine, Stavanger University Hospital, Stavanger, Norway.

Keijo Mäkelä (K)

The Finnish Arthroplasty Register, Helsinki, Finland.
Turku University Hospital and University of Turku, Turku, Finland.

Mikko S Venäläinen (MS)

Department of Medical Physics, Turku University Hospital, Turku, Finland.

Jinny Willis (J)

The New Zealand Joint Registry, Christchurch, New Zealand.

Michael Wyatt (M)

The New Zealand Joint Registry, Christchurch, New Zealand.

Chris Frampton (C)

The New Zealand Joint Registry, Christchurch, New Zealand.

Alexander Grimberg (A)

German Arthroplasty Registry, Berlin, Germany.

Arnd Steinbrück (A)

German Arthroplasty Registry, Berlin, Germany.

Yinan Wu (Y)

German Arthroplasty Registry, Berlin, Germany.

Cristiana Armaroli (C)

Arthroplasty Registry of the Autonomous Province of Trento, Clinical Epidemiology Service, Provincial Agency for Health Services of Trento, Trento, Italy.

Maria Adalgisa Gentilini (MA)

Arthroplasty Registry of the Autonomous Province of Trento, Clinical Epidemiology Service, Provincial Agency for Health Services of Trento, Trento, Italy.

Roberto Picus (R)

Arthroplasty Register of Autonomous Province of Bolzano, Observatory of Health, Health Department AP of Bolzano, Bolzano, Italy.

Mirko Bonetti (M)

Arthroplasty Register of Autonomous Province of Bolzano, Observatory of Health, Health Department AP of Bolzano, Bolzano, Italy.

Serban Dragosloveanu (S)

Romanian Arthroplasty Registry, Bucharest, Romania.
University of Medicine and Pharmacy-Carol Davila, Bucharest, Romania.
Foisor Orthopaedic Hospital, Bucharest, Romania.

Andreea E Vorovenci (AE)

Romanian Arthroplasty Registry, Bucharest, Romania.
Economic Cybernetics and Statistics Doctoral School, Bucharest University of Economic Studies, Bucharest, Romania.

Dan Dragomirescu (D)

Romanian Arthroplasty Registry, Bucharest, Romania.
Economic Cybernetics and Statistics Doctoral School, Bucharest University of Economic Studies, Bucharest, Romania.

Håvard Dale (H)

The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.

Christian Brand (C)

Swiss National Hip and Knee Joint Registry, Bern, Switzerland.
Institute of Social and Preventive Medicine, SwissRDL, University of Bern, Bern, Switzerland.

Bernhard Christen (B)

Swiss National Hip and Knee Joint Registry, Bern, Switzerland.
Articon, Bern, Switzerland.

Joanne Shapiro (J)

The National Joint Registry for England, Wales, Northern Ireland, The Isle of Man and Guernsey, London, United Kingdom.
NEC Software Solutions, Hemel Hempstead, United Kingdom.

J Mark Wilkinson (JM)

The National Joint Registry for England, Wales, Northern Ireland, The Isle of Man and Guernsey, London, United Kingdom.
Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.

Richard Armstrong (R)

The National Joint Registry for England, Wales, Northern Ireland, The Isle of Man and Guernsey, London, United Kingdom.
NEC Software Solutions, Hemel Hempstead, United Kingdom.

Kate Wooster (K)

The National Joint Registry for England, Wales, Northern Ireland, The Isle of Man and Guernsey, London, United Kingdom.
NEC Software Solutions, Hemel Hempstead, United Kingdom.

Geir Hallan (G)

The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.

Jan-Erik Gjertsen (JE)

The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.

Richard N Chang (RN)

Medical Device Surveillance and Assessment, Kaiser Permanente, San Diego, California.

Heather A Prentice (HA)

Medical Device Surveillance and Assessment, Kaiser Permanente, San Diego, California.

Art Sedrakyan (A)

Department of Population Health Sciences, Weill Medical College of Cornell University, New York, New York.

Elizabeth W Paxton (EW)

Medical Device Surveillance and Assessment, Kaiser Permanente, San Diego, California.

Ove Furnes (O)

The Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH